Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 119
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Skin Pharmacol Physiol ; 36(3): 140-148, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36863326

RESUMEN

INTRODUCTION: Dry skin is a hallmark of impaired skin barrier function. Moisturizers are a mainstay of treatment to help the skin retain moisture, and there is a high consumer demand for effective products. However, the development and optimization of new formulations are hampered due to lack of reliable efficacy measures using in vitro models. METHODS: In this study, a microscopy-based barrier functional assay was developed using an in vitro skin model of chemically induced barrier damage to evaluate the occlusive activity of moisturizers. RESULTS: The assay was validated by demonstrating the different effects on barrier function between humectant (glycerol) and occlusive (petrolatum). Significant changes in barrier function were observed upon tissue disruption, which was ameliorated by commercial moisturizing products. CONCLUSION: This newly developed experimental method may be helpful to develop new and improved occlusive moisturizers for the treatment of dry skin conditions.


Asunto(s)
Emolientes , Enfermedades de la Piel , Humanos , Emolientes/química , Piel , Vaselina/farmacología , Absorción Cutánea
2.
Int J Cosmet Sci ; 43(2): 218-224, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33336384

RESUMEN

BACKGROUND: An important trend in the personal care industry involves the development of body wash products that not only clean the skin without damage but deposit conditioning ingredients to improve skin barrier function. OBJECTIVE: The objective of this study was to develop skin biomarker measures to quantify the treatment effects of body wash products. METHODS: We employed analysis of structural proteins (keratin 1,10,11 and involucrin), a natural moisturizing factor (pyrrolidone carboxylic acid) and an inflammatory mediator (IL-1ra/IL-1α) from adhesive discs with dry skin grading, TEWL and capacitance measurements to compare the effects of direct application of petrolatum, a high petrolatum depositing body wash, and a regular body wash on dry leg skin in a standard leg-wash treatment protocol. RESULTS: High depositing body wash and petrolatum had positive effects on stratum corneum barrier function as judged by biomarker analysis, biophysical measurements and skin grading compared to the regular body wash product. CONCLUSIONS: The results clearly indicate that a combination of biomarker and biophysical property measurements is effective for determining the skin benefits of moisturizing body wash products.


CONTEXTE: Une tendance importante dans l'industrie des soins personnels inclut le développement de produits de lavage corporel qui non seulement nettoient la peau sans l'endommager, mais déposent des ingrédients de traitement pour améliorer la fonction de la barrière cutanée. OBJECTIF: L'objectif de cette étude était de développer des mesures de biomarqueurs cutanés permettant de quantifier les effets du traitement des produits de lavage corporel. MÉTHODES: Nous avons utilisé l'analyse de protéines structurelles (kératine 1,10,11 et involucrine), un facteur hydratant naturel (acide carboxylique de pyrrolidone) et un médiateur inflammatoire (IL-1ra/IL-1a) provenant de disques adhésifs avec cotation de la sécheresse cutanée, mesures de perte d'eau transépidermique (transepidermal water loss, TEWL) et de capacitance pour comparer les effets de l'application directe de vaseline, d'un produit de lavage corporel avec dépôt élevé de vaseline et d'un produit de lavage corporel ordinaire sur la peau sèche des jambes, dans un protocole de traitement de lavage des jambes standard. RÉSULTATS: Le produit de lavage corporel à dépôt élevé et la vaseline avaient des effets positifs sur la fonction de barrière de la couche cornée, comme évalué par l'analyse des biomarqueurs, les mesures biophysiques et la cotation de la peau, comparé au produit de lavage corporel ordinaire. CONCLUSIONS: Les résultats indiquent clairement qu'une combinaison de mesures des biomarqueurs et des propriétés biophysiques est efficace pour déterminer les bienfaits pour la peau des produits de lavage corporel hydratants.


Asunto(s)
Biomarcadores/metabolismo , Vaselina/farmacología , Piel/efectos de los fármacos , Adolescente , Adulto , Anciano , Femenino , Humanos , Persona de Mediana Edad , Adulto Joven
3.
Med Princ Pract ; 27(4): 372-377, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29723852

RESUMEN

OBJECTIVES: Glass ionomer cement (GIC) is routinely placed as a restorative material in dentistry. However, due to its poor physical properties, its use is limited to cases where the level of stress on restoration is minimal. Improved formulations of GIC have been developed to overcome these drawbacks. The purpose of this study was to evaluate flexural strength of a conventional GIC (Fuji IX) against a newly developed glass carbomer cement (GCP). MATERIALS AND METHODS: For Fuji IX and GCP, a total of 80 blocks were prepared and divided into 16 groups (n = 5). These groups were further categorized according to the storage medium (artificial saliva and Vaseline) and time intervals (24 h and 1, 2, and 4 weeks). A 3-point bending test was carried out, and statistical analysis was done using ANOVA and Tukey post hoc tests. RESULTS: Fuji IX showed a mean flexural strength of 25.14 ± 13.02 versus 24.27 ± 12.57 MPa for GCP. There was no significant statistical difference between both materials when compared under storage media. Both materials showed the highest value for flexural strength at 2 weeks of storage and lowest at 4 weeks. CONCLUSION: The storage media do not affect the flexural strength of the specimens with reference to time. Time is the unique factor with relative influence on mean resistance to fracture. Further testing is required to evaluate the true potential of the newly developed GCP.


Asunto(s)
Apatitas/farmacología , Resistencia Flexional , Cementos de Ionómero Vítreo/farmacología , Estrés Mecánico , Análisis de Varianza , Restauración Dental Permanente/métodos , Humanos , Bases Oleosas/farmacología , Vaselina/farmacología , Saliva
4.
J Allergy Clin Immunol ; 137(4): 1091-1102.e7, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26431582

RESUMEN

BACKGROUND: Petrolatum is a common moisturizer often used in the prevention of skin infections after ambulatory surgeries and as a maintenance therapy of atopic dermatitis (AD). However, the molecular responses induced by petrolatum in the skin have never been assessed. OBJECTIVE: We sought to define the cutaneous molecular and structural effects induced by petrolatum. METHODS: Thirty-six healthy subjects and 13 patients with moderate AD (mean SCORAD score, 39) were studied by using RT-PCR, gene arrays, immunohistochemistry, and immunofluorescence performed on control skin, petrolatum-occluded skin, and skin occluded with a Finn chamber only. RESULTS: Significant upregulations of antimicrobial peptides (S100A8/fold change [FCH], 13.04; S100A9/FCH, 11.28; CCL20/FCH, 8.36; PI3 [elafin]/FCH, 15.40; lipocalin 2/FCH, 6.94, human ß-defensin 2 [DEFB4A]/FCH, 4.96; P < .001 for all) and innate immune genes (IL6, IL8, and IL1B; P < .01) were observed in petrolatum-occluded skin compared with expression in both control and occluded-only skin. Application of petrolatum also induced expression of key barrier differentiation markers (filaggrin and loricrin), increased stratum corneum thickness, and significantly reduced T-cell infiltrates in the setting of "normal-appearing" or nonlesional AD skin, which is known to harbor barrier and immune defects. CONCLUSIONS: Petrolatum robustly modulates antimicrobials and epidermal differentiation barrier measures. These data shed light on the beneficial molecular responses of petrolatum in barrier-defective states, such as AD and postoperative wound care.


Asunto(s)
Antiinfecciosos/farmacología , Dermatitis Atópica/tratamiento farmacológico , Emolientes/farmacología , Vaselina/farmacología , Piel/efectos de los fármacos , Administración Cutánea , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antiinfecciosos/uso terapéutico , Biomarcadores/metabolismo , Estudios de Casos y Controles , Dermatitis Atópica/inmunología , Dermatitis Atópica/metabolismo , Emolientes/uso terapéutico , Femenino , Proteínas Filagrina , Humanos , Proteínas de Filamentos Intermediarios/metabolismo , Masculino , Proteínas de la Membrana/metabolismo , Persona de Mediana Edad , Vaselina/uso terapéutico , Piel/inmunología , Piel/metabolismo , Adulto Joven
5.
J Wound Care ; 25(9): 521-9, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27608513

RESUMEN

OBJECTIVE: To investigate the effect of a novel topical wound-healing agent, low-concentration povidone-iodine ointment (LPIO) with a hydrophobic white petrolatum-rich base on skin-wound models in rats and rabbits. METHOD: The therapeutic efficacy of topically applied LPIO was compared to that of standard-concentration povidone-iodine ointment (SPIO) and non-treatment control, using a full-thickness skin-wound model in 24 hairless rats and a full-thickness skin-defect model in rabbit earlobes. The animals were kept under standardised conditions at the Central Research Laboratory of Maruishi Pharmaceutical Co. Ltd. (Osaka, Japan). Therapeutic efficacy was evaluated based on macroscopic wound-size reduction, as well as histopathological and immuno-histochemical examinations. RESULTS: LPIO enhanced wound healing in rat full-thickness skin ulcers, reducing wound size and inflammation, when compared with that in SPIO and non-treatment control. LPIO also markedly improved wound healing in rabbit earlobe ulcers by significantly improving re-epithelialisation, compared with that in SPIO. CONCLUSION: The results of this study suggest that LPIO is a useful topical therapy for ulcerative lesions.


Asunto(s)
Antiinfecciosos Locales/farmacología , Povidona Yodada/farmacología , Úlcera Cutánea/tratamiento farmacológico , Cicatrización de Heridas/efectos de los fármacos , Animales , Modelos Animales de Enfermedad , Pomadas , Vaselina/farmacología , Conejos , Ratas
6.
J Allergy Clin Immunol ; 134(2): 362-72, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24768652

RESUMEN

BACKGROUND: Allergic contact dermatitis (ACD) is the most common occupational disease. Although murine contact hypersensitivity provides a framework for understanding ACD, it carries important differences from its human counterpart. Unlike the contact hypersensitivity model, which is induced by potent sensitizers (ie, dinitrofluorobenzene), human ACD is induced by weak-to-moderate sensitizers (ie, nickel), which cannot induce reactions in mice. Distinct hapten-specific immune-polarizing responses to potent inducers were suggested in mice, with unclear relevance to human ACD. OBJECTIVE: We explored the possibility of distinct T-cell polarization responses in skin to common clinically relevant ACD allergens. METHODS: Gene-expression and cellular studies were performed on common allergens (ie, nickel, fragrance, and rubber) compared with petrolatum-occluded skin, using RT-PCR, gene arrays, and immunohistochemistry. RESULTS: Despite similar clinical reactions in all allergen groups, distinct immune polarizations characterized different allergens. Although the common ACD transcriptome consisted of 149 differentially expressed genes across all allergens versus petrolatum, a much larger gene set was uniquely altered by individual allergens. Nickel demonstrated the highest immune activation, with potent inductions of innate immunity, TH1/TH17 and a TH22 component. Fragrance, and to a lesser extent rubber, demonstrated a strong TH2 bias, some TH22 polarization, and smaller TH1/TH17 contributions. CONCLUSIONS: Our study offers new insights into the pathogenesis of ACD, expanding the understanding of T-cell activation and associated cytokines in allergen-reactive tissues. It is the first study that defines the common transcriptome of clinically relevant sensitizers in human skin and identifies unique pathways preferentially activated by different allergens, suggesting that ACD cannot be considered a single entity.


Asunto(s)
Alérgenos/farmacología , Dermatitis Alérgica por Contacto/genética , Piel/efectos de los fármacos , Transcriptoma/inmunología , Adulto , Animales , Antígenos CD/genética , Antígenos CD/inmunología , Citocinas/genética , Citocinas/inmunología , Dermatitis Alérgica por Contacto/inmunología , Dermatitis Alérgica por Contacto/patología , Femenino , Perfilación de la Expresión Génica , Haptenos/inmunología , Haptenos/farmacología , Humanos , Masculino , Ratones , Persona de Mediana Edad , Níquel/inmunología , Níquel/farmacología , Pruebas del Parche , Perfumes/farmacología , Vaselina/farmacología , Goma/farmacología , Piel/inmunología , Piel/patología , Especificidad de la Especie , Subgrupos de Linfocitos T/efectos de los fármacos , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/patología , Balance Th1 - Th2/efectos de los fármacos
7.
J Eur Acad Dermatol Venereol ; 28(11): 1522-8, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24320057

RESUMEN

BACKGROUND: The most common side-effect of ablative fractional skin resurfacing in Asians is post inflammatory hyperpigmentation (PIH). Various attempts have been made to reduce the occurrence of PIH after laser treatment including sun avoidance, the use of preoperative and postoperative treatment regimens, and treatment using conservative energy settings and epidermal protection. OBJECTIVES: To determine whether the use of broad-spectrum sunscreen with anti-inflammatory agents starting on the first day after fractional CO2 laser skin resurfacing reduces the incidence of post laser PIH. MATERIALS AND METHODS: Thirty patients were treated with ablative fractional CO2 resurfacing on both sides of their faces at 10 mJ and 10% density. Each subject was randomly treated on one side of the face with petrolatum ointment four times a day for the first week after laser treatment and on the other side of the face with petrolatum ointment four times a day plus broad-spectrum sunscreen with anti-inflammatory agents in the morning starting on the first day after laser treatment. Transepidermal water loss was recorded at baseline and every day for 1 week. Melanin and erythema indexes were measured at baseline, 1-, 2-week, 1-, 2- and at 3-month post treatment. RESULTS: Of the 30 patients involved in the study, 26 received the treatment and attended 1-, 2-week, 1-, 2- and 3-month post-treatment visits. Four patients were withdrawn from the study because they could not attend every follow-up visit. There was no statistically significant difference in transepidermal water loss at baseline, immediately after laser treatment, or at the D1 to D7 follow-up visits. Erythema index had no significantly statistical difference at baseline, 1-, 2- and at 3-month after laser treatment. Furthermore, there was a statistically significant difference in melanin index at 1-week post laser treatment between both sides (P = 0.001). Melanin index at the 1-week follow-up visit on the side treated with broad-spectrum sunscreen with anti-inflammatory agents starting on the first day after laser treatment was significantly less than the control side. CONCLUSION: The use of broad-spectrum sunscreen with anti-inflammatory agents starting on the first day after ablative fractional skin resurfacing can decrease the incidence of PIH after laser treatment at 1-week postoperatively.


Asunto(s)
Antiinflamatorios/uso terapéutico , Epidermis/cirugía , Hiperpigmentación/etiología , Hiperpigmentación/prevención & control , Terapia por Láser/efectos adversos , Láseres de Gas/efectos adversos , Protectores Solares/uso terapéutico , Adulto , Anciano , Antiinflamatorios/farmacología , Cicatriz/cirugía , Terapia Combinada , Procedimientos Quirúrgicos Dermatologicos/efectos adversos , Eritema/epidemiología , Femenino , Estudios de Seguimiento , Humanos , Hiperpigmentación/epidemiología , Masculino , Melaninas/metabolismo , Persona de Mediana Edad , Vaselina/farmacología , Vaselina/uso terapéutico , Prevalencia , Piel/efectos de los fármacos , Piel/metabolismo , Protectores Solares/farmacología , Resultado del Tratamiento
8.
J Pharm Sci ; 113(5): 1299-1305, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38103688

RESUMEN

Although laurocapram (Azone) significantly enhances the skin permeation of drugs, its development was hindered by its skin irritation. We then developed an Azone-mimic ionic liquid (IL-Azone), composed of less irritating cationic ε-caprolactam and anionic myristic acid. IL-Azone dissociates to the original cation and anion in the presence of water in the formulation. We tried to select a formulation suitable for IL-Azone in the present study. Each formulation contained 5 % of either Azone or IL-Azone along with the model drug antipyrine, and skin permeation experiments of the drug were conducted. The results revealed that IL-Azone did not enhance skin permeation when combined with most formulations tested. However, a notable and rapid enhancement in skin permeation was observed when combined with white petrolatum. This effect could be attributed to the minimal water content in white petrolatum, which prevented IL-Azone degradation. Furthermore, its permeation-enhancing effects from IL-Azone in white petrolatum were more pronounced and rapid than Azone. The rapid onset observed with IL-Azone can be attributed to its degradation into its original components at the interface between the stratum corneum and the living epidermis, which results in a shorter lag time before achieving a steady-state concentration in the SC compared to Azone.


Asunto(s)
Azepinas , Líquidos Iónicos , Absorción Cutánea , Piel/metabolismo , Vaselina/metabolismo , Vaselina/farmacología , Agua/metabolismo , Administración Cutánea
9.
J Clin Pediatr Dent ; 37(3): 257-62, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23855169

RESUMEN

AIM: this study was conducted to evaluate the antimicrobial effectiveness of 6 root canal filling materials and a negative control agent against 18 strains of bacteria isolated from infected root canals of primary molar teeth using agar diffusion assay. MATERIALS: Aloevera with sterile water Zinc oxide and Eugenol, Zinc oxide-Eugenol with aloevera, Calcium hydroxide and sterile water, Calcium hydroxide with sterile water and aloevera, Calcium hydroxide and Iodoform (Metapex) and Vaseline (Control). MIC and MBC of aloevera was calculated. RESULTS: All materials except Vaseline showed varied antimicrobial activity against the test bacterias. The zones of inhibition were ranked into 4 inhibition categories based on the proportional distribution of the data. All the 18 bacterial isolates were classified under 2 groups based on Gram positive and Gram negative aerobes. Statistical analysis was carried out to compare the antimicrobial effectiveness between materials tested with each of the bacterial groupings. CONCLUSION: Aloevera + Sterile Water was found to have superior antimicrobial activity against most of the microorganisms followed by ZOE + Aloevera, calcium hydroxide + Aloevera, ZOE, calcium hydroxide, Metapex in the descending order and Vaseline showed no inhibition.


Asunto(s)
Aloe , Antibacterianos/farmacología , Cavidad Pulpar/microbiología , Bacterias Anaerobias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Extractos Vegetales/farmacología , Materiales de Obturación del Conducto Radicular/farmacología , Diente Primario/microbiología , Antibacterianos/administración & dosificación , Antiinfecciosos Locales/administración & dosificación , Antiinfecciosos Locales/farmacología , Hidróxido de Calcio/administración & dosificación , Hidróxido de Calcio/farmacología , Niño , Preescolar , Fístula Dental/microbiología , Necrosis de la Pulpa Dental/microbiología , Combinación de Medicamentos , Humanos , Hidrocarburos Yodados/administración & dosificación , Hidrocarburos Yodados/farmacología , Ensayo de Materiales , Pruebas de Sensibilidad Microbiana , Diente Molar/microbiología , Absceso Periapical/microbiología , Vaselina/farmacología , Extractos Vegetales/administración & dosificación , Aceites de Silicona/administración & dosificación , Aceites de Silicona/farmacología , Cemento de Óxido de Zinc-Eugenol/administración & dosificación , Cemento de Óxido de Zinc-Eugenol/farmacología
10.
Cir Cir ; 91(5): 596-600, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37844881

RESUMEN

OBJECTIVE: To compare the protective effect of nitroglycerin ointment 2% and Dimethylsulfoxide (DMSO) in dorsal flaps of the rat. METHODS: A blind, experimental study was conducted in 24 male Wistar rats, with a mean weight of 320 (286-376) grams. Group 1: Control. Petrolatum jelly (Vaseline), n = 8, Group 2: Nitroglycerin (NTG) ointment 2% (Nitro-Bid, Altana Co.) n = 8, and Group 3: DMSO gel 90% (Neogen corp. Lexington KY, 40611), n = 8. RESULTS: A total of 24 rats were operated on in the 6-month period of this study. Using a non-parametric Mann-Whitney U-test analysis, a statistically significant p was obtained between the control group and 2% NTG ointment, both in the area of necrosis and in the healthy area (p = 0.026). In contrast, the comparison between DMSO [CH3) 2SO] and the control group (p = 0.180) and between both study groups, with a p = 0.18, was not significant. CONCLUSIONS: Our study concluded that there is a protective effect of 2% NTG ointment for flap survival in relation to the control group (petrolatum). DMSO administered topically did not show a protective effect, compared to the control group.


OBJETIVO: Comparar el efecto protector del ungüento de nitroglicerina 2% y el dimetilsulfoxido 90% en colgajos dorsales en ratas. MÉTODOS: Se realizó un estudio experimental ciego en 24 ratas Wistar macho, con un peso medio de 320 gramos. Grupo 1: Control. Petrolato n = 8, Grupo 2: Nitroglicerina unguento al 2 % (Nitro-Bid, Altana Co.), n = 8, Grupo 3. Dimetilsulfóxido al 90% (Neogen corp. Lexington KY.), n = 8. RESULTADOS: Un total de 24 ratas fueron operadas en el período de 6 meses de este estudio. Mediante un análisis no paramétrico de la prueba U de Mann Whitney, se obtuvo una p estadísticamente significativa entre el grupo control y la pomada de nitroglicerina al 2%, tanto en el área de necrosis como en el área sana (p = 0.026). Por el contrario, la comparación entre DMSO y el grupo control (p = 0.180) y entre ambos grupos de estudio, con una p = 0.18, no fue significativa. CONCLUSIONES: Nuestro estudio concluyó que existe un efecto protector de la pomada de nitroglicerina al 2% para la supervivencia del colgajo en relación al grupo control (vaselina). El DMSO administrado por vía tópica no mostró un efecto protector, en comparación con el grupo de control.


Asunto(s)
Dimetilsulfóxido , Nitroglicerina , Ratas , Masculino , Animales , Nitroglicerina/farmacología , Dimetilsulfóxido/farmacología , Pomadas , Ratas Wistar , Necrosis/prevención & control , Vaselina/farmacología
11.
Saudi Med J ; 44(1): 106-109, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36634956

RESUMEN

OBJECTIVES: To update a possible role of cosmeceutical topic treatment to obtain a better scar. METHODS: This is a preliminary supportive study. A total of 14 patients who went to the General Hospital of Mexico City, Mexico, between May and December 2020, for breast reconstruction were included in the current study. The biopsies were carried out to the scar area of the previous I° and II° surgery. The patients were thus divided into 2 groups: those who used Cicolea cream® as a treatment supplement and those who used only petrolatum. RESULTS: Collagen fibers arranged in a regular pattern in the group treated with Cicolea compared to dispersed collagen fibers in the group treated with pure petrolatum. Furthermore, the patients who presented hypertrophic or keloid scars secondary to mastectomy, developed after insertion of breast expanders an organized scarring process, with improvement of scar if treated with Cicolea. CONCLUSION: Based on our observations, it is possible to propose that the action of the polyphenols present in the different components of Cicolea® cream leads to a better evolution of the wound healing compared to the action of petrolatum composition.


Asunto(s)
Neoplasias de la Mama , Cicatriz Hipertrófica , Humanos , Femenino , Neoplasias de la Mama/patología , Cicatriz Hipertrófica/prevención & control , Mastectomía/efectos adversos , Cicatrización de Heridas , Piel/patología , Vaselina/farmacología , Colágeno/farmacología
12.
Artículo en Inglés | MEDLINE | ID: mdl-36554558

RESUMEN

Excipients are used as vehicles for topical treatments; however, there are not many studies that evaluate the impact of different excipients themselves. The aim of this research is to assess skin homeostasis changes in healthy individuals after using water/oil (W/O), oil/water (O/W), Beeler base, foam and Vaseline excipients. A within-person randomized trial was conducted that included healthy individuals without previous skin diseases. Skin barrier function parameters, including stratum corneum hydration (SCH), transepidermal water loss (TEWL), pH, temperature, erythema, melanin and elasticity (R0, R2, R5 and R7), were measured on the volar forearm before and after using each excipient. Sixty participants were included in the study, with a mean age of 32 years. After applying w/o excipient erythema decreased by 25 AU, (p < 0.001) and elasticity increased by 6%. After using the o/w excipient, erythema decreased by 39.36 AU (p < 0.001) and SCH increased by 6.85 AU (p = 0.009). When applying the Beeler excipient, erythema decreased by 41.23 AU (p < 0.001) and SCH increased by 15.92 AU (p < 0.001). Foam and Vaseline decreased TEWL and erythema. Excipients have a different impact on skin barrier function. Knowing the effect of excipients on the skin could help to develop new topical treatments and help specialists to choose the best excipient according to the pathology.


Asunto(s)
Excipientes , Piel , Humanos , Adulto , Excipientes/farmacología , Vaselina/farmacología , Administración Tópica , Eritema
13.
J Drugs Dermatol ; 10(7): 735-43, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21720655

RESUMEN

Corticosteroids are the mainstay of therapy for atopic dermatitis, but long-term use is associated with adverse effects. We sought to evaluate the clinical efficacy of two steroid-sparing creams for atopic dermatitis. Twenty patients were enrolled in an investigator-blinded, bilateral comparison study. Patients applied pimecrolimus cream twice daily to a target lesion on one side of the body and also applied a topical medical device cream three times daily on a symmetrical target lesion on the opposite side of the body for four weeks. Clinical assessments including Physician Global Assessment (PGA), Target Lesion Symptom Score (TLSS), subject self-assessment and digital photography were performed at the baseline, 2 week, and 4 week visits. Seventy-five percent of patients (pimecrolimus, 15 of 20; topical medical device, 15 of 20) were rated "clear" (0) or "almost clear" (1) by PGA for both medications after four weeks. Percent improvement of the PGA from randomization for pimecrolimus cream and the topical medical device cream were 72.50 and 71.67 respectively (P=0.9283). PGA scores decreased significantly from baseline for both treatments (P=0.004). Overall, there was no statistically significant difference between treatment groups for PGA scores throughout the study (P=0.8236). No cutaneous side effects were noted. Our study was limited by a small sample size and lack of double-blinding; however, both treatments were found to be safe and effective in treating atopic dermatitis over four weeks. Significant improvements were noted for all efficacy variables. In conclusion, a lipid-rich, non-steroidal, topical medical device cream was as effective in improving atopic dermatitis as pimecrolimus cream.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Cetomacrogol/farmacología , Dermatitis Atópica/tratamiento farmacológico , Fármacos Dermatológicos/uso terapéutico , Alcoholes Grasos/farmacología , Aceite Mineral/farmacología , Vaselina/farmacología , Tacrolimus/análogos & derivados , Administración Cutánea , Administración Tópica , Adolescente , Adulto , Antiinflamatorios no Esteroideos/efectos adversos , Cetomacrogol/efectos adversos , Fármacos Dermatológicos/efectos adversos , Combinación de Medicamentos , Alcoholes Grasos/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Aceite Mineral/efectos adversos , Vaselina/efectos adversos , Método Simple Ciego , Tacrolimus/efectos adversos , Tacrolimus/uso terapéutico , Resultado del Tratamiento , Adulto Joven
14.
Int Wound J ; 8(1): 69-73, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21159127

RESUMEN

The purpose of this study was to compare the rate of wound healing in diabetic foot ulcers (DFU) using either a microbial cellulose (MC) wound dressing or Xeroform™ Petrolatum gauze. In a parallel, open-label trial in which the primary outcome was the rate of wound healing and the time to wound closure, 15 ulcers in type II diabetic patients received an MC dressing. Wounds in 19 control patients with type II diabetes were treated with a Xeroform gauze dressing. All wounds were non infected, Wagner stage II or III and received standard care including debridement, non weight bearing limb support and weekly wound evaluation. The mean time to heal in the MC (±SE) treated group was 32 days ± 2.5 and for controls it was 48 days ± 4.7 (P < 0.01). The rate of weekly wound closure (mean ± SE) was 1.7 times faster in the MC-treated group (cellulose treated, -5.04% per week ± 0.38 versus control, -2.93% per week ± 0.19), (P < 0.001). Among covariants tested by univariate regression, only the original wound area correlated with the time to wound closure (P < 0.001). In conclusion, with the provision of current standards of care, the application of an MC dressing to a diabetic ulcer may enhance the rate of wound healing and shorten the time course of epithelisation.


Asunto(s)
Vendajes , Celulosa , Pie Diabético/terapia , Vaselina/farmacología , Cicatrización de Heridas/efectos de los fármacos , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
15.
Am J Trop Med Hyg ; 102(2): 468-475, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31802727

RESUMEN

Wound dressings are always needed after skin injury; however, most of the dressings still leave room for improvement. Here, we would like to develop an effective dressing with the ability to improve wound healing. A chitosan-Vaseline gauze (CVG) dressing was developed by coating the chitosan mixture and Vaseline on sterile gauze with subsequent drying. Infrared spectroscopy and electron microscopy were used to investigate the miscibility and structure of the dressing. The cytotoxicity and antibacterial nature were evaluated in vitro. The studies of water retention rate, wound healing, and tissue compatibility were carried out over a period of 14 days on full-thickness skin wounds of male Sprague-Dawley rats. It was observed that the CVG dressing demonstrated functional structure by miscibility, non-cytotoxicity, and good antibacterial effects against both Gram-positive and Gram-negative bacteria. The water retention rate incresased up to 25% after applying CVG for 3 hours. Besides, CVG treatment increased angiogenesis and improved microvascular density in wounds. The wounds treated with CVG showed size deduction with new collagen aggregations similar to those in the normal dermis. All the aforementioned results suggest that CVG dressing could be a promising candidate for wound treatment.


Asunto(s)
Vendajes , Quitosano/farmacología , Vaselina/farmacología , Cicatrización de Heridas/efectos de los fármacos , Animales , Antibacterianos , Supervivencia Celular , Quitosano/administración & dosificación , Escherichia coli , Masculino , Ratones , Células 3T3 NIH , Vaselina/administración & dosificación , Ratas , Ratas Sprague-Dawley , Staphylococcus aureus
16.
Sci Rep ; 9(1): 4320, 2019 03 13.
Artículo en Inglés | MEDLINE | ID: mdl-30867534

RESUMEN

Non-adhering dressings are commonly used during granulation, tissue formation, and re-epithelialization. Elucidating cytotoxic effects and influence on proliferation/migration capacity of cells like fibroblasts is of interest. Dressings' effects were investigated by comprehensive in vitro approach: (1) MTT assay measuring cell viability after direct contact, (2) ATP assay determining effects on cell proliferation, and (3) scratch wound assay featuring an in vitro wound healing model. One cotton-based dressing with vaseline (vas) was included in the study and four polyester dressings containing vas and technology-lipido-colloid matrix (TLC), carboxymethylcellulose (CMC), hydrocolloid (HC), or glycerin (gly) as additives. A polyamide dressing with vas + CMC and three silicone-based dressings (AT, CC, M) were tested. Polyester + vas + CMC did not negatively affect cell viability or proliferation but it was found that fibroblast layers appeared more irregular with decreased F-actin network structure and tubulin density possibly leading to hampered scratch closure. Silicone AT, polyester + gly and polyamide + vas + CMC caused distinct cell damage. The latter two further reduced cell viability, proliferation and scratch healing. From the overall results, it can be concluded that cotton + vas, polyester + TLC, polyester + vas + HC and the silicone dressings CC and M have the potential to prevent damage of newly formed tissue during dressing changes and positively influence wound healing.


Asunto(s)
Vendajes/normas , Proliferación Celular , Fibroblastos/citología , Cicatrización de Heridas , Animales , Carboximetilcelulosa de Sodio/farmacología , Línea Celular , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Coloides/farmacología , Fibra de Algodón , Glicerol/farmacología , Humanos , Vaselina/farmacología , Poliésteres/farmacología , Siliconas/farmacología , Cicatrización de Heridas/efectos de los fármacos
17.
Int J Antimicrob Agents ; 54(5): 610-618, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31356860

RESUMEN

Skin bacterial colonization/infection is a frequent cause of morbidity in patients with chronic wounds and allergic/inflammatory skin diseases. This study aimed to develop a novel approach to eradicate meticillin-resistant Staphylococcus aureus (MRSA) from human skin. To achieve this, the stability and antibacterial activity of the novel LL-37-derived peptide P10 in four ointments was compared. Results indicate that P10 is chemically stable and antibacterial in hypromellose gel and Softisan-containing cream, but not in Cetomacrogol cream (with or without Vaseline), at 4 °C for 16 months. Reduction in MRSA counts on Leiden human epidermal models (LEMs) by P10 in hypromellose gel was greater than that of the peptide in Cetomacrogol cream or phosphate buffered saline. P10 did not show adverse effects on LEMs irrespective of the ointment used, while Cetomacrogol with Vaseline and Softisan cream, but not hypromellose gel or Cetomacrogol cream, destroyed MRSA-colonized LEMs. Taking all this into account, P10 in hypromellose gel dose-dependently reduced MRSA colonizing the stratum corneum of the epidermis as well as biofilms of this bacterial strain on LEMs. Moreover, P10 dose-dependently reduced MRSA counts on ex-vivo human skin, with P10 in hypromellose gel being more effective than P10 in Cetomacrogol and Softisan creams. P10 in hypromellose gel is a strong candidate for eradication of MRSA from human skin.


Asunto(s)
Antibacterianos/farmacología , Péptidos Catiónicos Antimicrobianos/farmacología , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Pomadas/farmacología , Infecciones Cutáneas Estafilocócicas/tratamiento farmacológico , Administración Tópica , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Cetomacrogol/farmacología , Portadores de Fármacos/farmacología , Humanos , Derivados de la Hipromelosa/farmacología , Lípidos/farmacología , Pruebas de Sensibilidad Microbiana , Vaselina/farmacología , Piel/microbiología , Catelicidinas
18.
J R Soc Interface ; 15(143)2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29950516

RESUMEN

Retention of hydrophobic active agents on human skin following the use of skin-care formulations is an important indication of the performance of the deposited product. We have developed a novel system which replicates the interaction between human skin and a cosmetic emulsion to systematically establish and characterize the key parameters driving the retention process at the interface. This included a comprehensive study of the skin's biology and physical properties which influenced the process, the fabrication of advanced, improved skin biomimics, the formulation of a cosmetic model-system emulsion, comprising a hydrophobic active agent i.e. petrolatum, commonly used in cosmetic products, the development of a dedicated and highly consistent deposition rig with a corresponding cleaning set-up and the systematic characterization of retention processes on the developed mimics. This study further explores the interplay of petrolatum with skin biomimics and studies the mechanisms that give rise to improved interfacial retention. Petrolatum has been found to create an occlusive layer on the skin mimic, displaying high coverage from emulsion formulations. The large particle size emulsions yielded improved retention on the developed skin biomimics due to the microstructure of the emulsion and the counter effect of the surfactant.


Asunto(s)
Cosméticos , Vaselina , Piel/metabolismo , Tensoactivos , Cosméticos/química , Cosméticos/farmacología , Emulsiones , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Tamaño de la Partícula , Vaselina/química , Vaselina/farmacología , Tensoactivos/química , Tensoactivos/farmacología
19.
Wounds ; 30(9): 310-316, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30256746

RESUMEN

BACKGROUND: A new skin protectant with improved adhesion to denuded skin and resistance to wash off has been developed to protect skin from incontinence-associated dermatitis (IAD) or general loss of skin integrity. OBJECTIVE: This controlled, randomized, prospective, open-label study determines the durability of the new protectant when applied to intact skin in 21 healthy human volunteers and compares it to 3 other products used for similar clinical indications. MATERIALS AND METHODS: Eight 0.75-in circles of black carbon pigment were applied to the bilateral forearms (4 per arm to allow for duplicates) of the participants and covered with the various products. Participants conducted normal routine activities over 7 days. Photographs were taken and a test site assessment was completed before and after application of the products on day 0 and at days 1, 2, 3, 4, and 7 to evaluate pigment loss over time. Carbon integrated optical density (CIOD) was measured under the assumption that a loss of pigment correlated with a loss of the protective product. These data were used to calculate the percent barrier remaining over time. RESULTS: The percent of intact film was significantly greater (P < .05) from day 3 onwards for the new skin protectant compared with the other 3 products. The new product showed no significant change in CIOD (P = .46) from day 1 through day 7, indicating no meaningful wear over time. The other 3 products showed significant changes in CIOD (P < .01) beginning at either day 2 or day 3. CONCLUSIONS: The new skin protectant was more durable than the other products tested. It remained in place for up to 7 days for all participants, whereas the other products had < 50% remaining on the skin by that time point.


Asunto(s)
Dermatitis/terapia , Fármacos Dermatológicos/farmacología , Vaselina/farmacología , Crema para la Piel/farmacología , Óxido de Zinc/farmacología , Administración Tópica , Adulto , Anciano , Dermatitis/prevención & control , Fármacos Dermatológicos/administración & dosificación , Femenino , Antebrazo/patología , Voluntarios Sanos , Humanos , Masculino , Persona de Mediana Edad , Vaselina/administración & dosificación , Estudios Prospectivos , Crema para la Piel/administración & dosificación , Resultado del Tratamiento , Incontinencia Urinaria/complicaciones , Óxido de Zinc/administración & dosificación
20.
Yakugaku Zasshi ; 138(11): 1417-1424, 2018.
Artículo en Japonés | MEDLINE | ID: mdl-30381650

RESUMEN

When selecting external medicines for the treatment of skin diseases, it is thought to be very important to consider differences in characteristics of their bases, because the bases may influence the clinical efficacy of the medicines. In this study, we investigated whether the differences in characteristics of three kinds of bases, white petrolatum, macrogol ointment, and aqueous gel affect wound healing. In vitro moisture permeability tests demonstrated that these bases have different characteristics in coatability and water retentivity, with the rank order of the intensity of coatability as white petrolatum>macrogol ointment>aqueous gel, and that of water retentivity as macrogol ointment>white petrolatum>aqueous gel. Similar rank order of these bases was observed for transepidermal water loss and stratum corneum water content in the dry skin on the abdomen of guinea pigs induced by topical application of acetone/ether mixture, followed by water. In addition, we found that treatment with macrogol ointment, but not white petrolatum or aqueous gel, significantly accelerated wound healing in rat skin, and that the contents of basic fibroblast growth factor and epidermal growth factor in the skin treated with macrogol ointment were significantly higher compared with non-treated skin. In conclusion, these results imply an important role of the bases of external medicines in the treatment of skin diseases.


Asunto(s)
Bases Oleosas/farmacología , Polietilenglicoles/farmacología , Cicatrización de Heridas/efectos de los fármacos , Animales , Fenómenos Químicos , Factor de Crecimiento Epidérmico/metabolismo , Femenino , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Geles , Cobayas , Interacciones Hidrofóbicas e Hidrofílicas , Masculino , Pomadas , Permeabilidad , Vaselina/farmacología , Ratas Sprague-Dawley , Piel/metabolismo , Agua/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA